Clinical Practice guidelines— Telegram Channel

Fixed-Dose Combination Therapy for the Prevention of Cardiovascular Diseases in CKD

Orforglipron is the first FDA-approved non-peptide oral GLP-1 agonist (2026), offering injection-free obesity treatment with strong potential to change future diabetes and weight management guidelines…

☑️ Potassium salts include: ✔️ potassium chloride ✔️ potassium phosphate ✔️ and potassium bicarbonate. 🔘 Potassium phosphate is found primarily in food 👉 and potassium bicarbonate is typically r…

☑️ The FINEARTS-HF trial demonstrated👉👉 that finerenone 👉 a novel and selective nonsteroidal MRA 👉 was effective in reducing total HF events (comprised of 👉 first 👉and recurrent hospitalizat…

The lack of apparent beneft from👉 neprilysin inhibitionin patients with 👉HFpEF🚨👉 compared to those with HFrEF